Login / Signup
Active surveillance in intermediate-risk prostate cancer.
Laurence H Klotz
Published in:
BJU international (2020)
The benefits of AS make it an appealing option for selected patients with intermediate-risk disease.
Keyphrases
</>
prostate cancer
radical prostatectomy